AGP Executive Report
Last update: 3 hours agoLeadership Shake-Up in Malaysia: KPJ Healthcare Bhd president/MD Chin Keat Chyuan resigns effective Sept 1, with chief medical director Prof Dr Hanafiah Harunarashid taking over as officer-in-charge pending a new appointment. China Oncology Update: China’s NMPA CDE accepted the NDA for opamtistomig (LBL-024), a PD-L1/4-1BB bispecific antibody, for previously treated advanced extrapulmonary neuroendocrine carcinoma, with priority review granted. India Medical Education Focus: Experts say India must improve medical education quality—faculty, resources, simulation, and responsible AI use—rather than only expanding seats; meanwhile Andhra Pradesh invited tenders worth about Rs 221 crore for AYUSH and hospital/college infrastructure. Public Health & Safety: Japan’s express train hit track workers doing weed control, killing four; in India, Delhi health officials again stressed no shortage of beds/equipment amid H1N1 concerns. Healthcare Business Moves: Colgate-Palmolive India appoints Manish Anandani as India MD & CEO, while Prabha Narasimhan shifts to an Asia-Pacific leadership role. Women’s Health Access: Thane Civil Hospital’s menopause clinic earns UNFPA praise for centralized, free care for economically weaker women.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
